《Table 4 Comparison of IOP alterations for combined IVTA+IVB group and only IVB group》

《Table 4 Comparison of IOP alterations for combined IVTA+IVB group and only IVB group》   提示:宽带有限、当前游客访问压缩模式
本系列图表出处文件名:随高清版一同展现
《贝伐单抗单用与联合曲安奈德治疗糖尿病性黄斑水肿的疗效比较(英文)》


  1. 获取 高清版本忘记账户?点击这里登录
  1. 下载图表忘记账户?点击这里登录
aMann Whitney-U test P<0.05.bIndependent Sample t test P<0.05.IVTA:Intravitreal triamcinolon+bevacizumab;IVB:Intravitreal bevacizumab;IOP:Intraocular pressure.

Before the administration of the drugs,CMT obtained by OCT was 494.7±114.4μm in the IVB group,and 546.8±165.6μm in the IVB+IVTA group,and there was no significant difference between them(P=0.243).Also,there was no significant difference in initial VAs(57.1±13.50 in IVB,48.9±13.90 in IVTA+IVB,P=0.59)and IOPs(15.6±3.20 mm Hg in IVB,15.8±3.10 mm Hg in IVTA+IVB,P=0.779)between two groups(Table 1).